Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Psychopharmacology (Berl). 2011 May 28;218(3):579–587. doi: 10.1007/s00213-011-2343-z

Fig. 3.

Fig. 3

A hyperbolic curve fit of dopamine D2/D3 (a) ([11C]raclopride (filled circle) and [11C]MNPA (empty circle)) and (b) serotonin 5-HT1A ([carbonyl-11C]WAY-100635 (filled circle)) receptor occupancy plotted as a function of cariprazine dose (µg/kg). Receptor occupancy reflects the percent change in BPND estimated by MRTM2 under the post-dose drug treatment condition compared with baseline measurements